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OBJECTIVES We sought to define the prognostic implications of the extent and severity of exercise
echocardiographic abnormalities in patients with good exercise capacity.
BACKGROUND The exercise capacity of patients with known or suspected coronary artery disease (CAD) is
of prognostic importance, as is the extent of exercise-related left ventricular (LV) hypoper-
fusion or dysfunction.
METHODS We examined the outcomes of 1,874 patients with known or suspected CAD (mean age 64
10 years, 64% men) who had good exercise capacity (5 metabolic equivalents [METs] for
women, 7 METs for men) but abnormal exercise echocardiograms and analyzed the
potential association between clinical, exercise and echocardiographic variables and subse-
quent cardiac events.
RESULTS Multivariate predictors of time to cardiac death or nonfatal myocardial infarction (MI) were
diabetes mellitus (risk ratio [RR] 1.88; 95% confidence interval [CI] 1.2 to 3.0), history of MI
(RR 2.44; 95% CI 1.6 to 3.6) and an increase or no change in LV end-systolic size in response
to exercise (RR 1.61; 95% CI 1.1 to 2.5). Using echocardiographic variables that were of
incremental prognostic value, we were able to stratify the cardiac risk of the study population;
cardiac death or nonfatal MI rate per person-year of follow-up was 1.6% for patients who had
a decrease in LV end-systolic size in response to exercise (n  1,330) and 1.2% for patients
who did not have any severely abnormal LV segments immediately after exercise (n  868).
CONCLUSIONS In patients with good exercise capacity, echocardiographic descriptors of the extent and
severity of exercise-related LV dysfunction were of independent and incremental prognostic
value. Stratification of patients into low- and higher risk subgroups was possible using these
exercise echocardiographic characteristics. (J Am Coll Cardiol 2002;39:1345–52) © 2002
by the American College of Cardiology Foundation
For patients with known or suspected coronary artery
disease (CAD), the prognostic importance of exercise ca-
pacity is well established (1–5). The extent of exercise-
related left ventricular (LV) hypoperfusion or dysfunction,
as measured by nuclear scintigraphy, has also been shown to
be of prognostic value (6,7). Published information is
See page 1353
limited regarding the prognostic value of the degree of
exercise-related LV dysfunction, as measured by two-
dimensional echocardiography (8).
The prognosis of patients after normal exercise echocar-
diography is favorable. Recently, we demonstrated that
women who can exercise into stage 2 of the Bruce protocol
(5 metabolic equivalents [METs]) and men who can
exercise into stage 3 (7 METs) have an excellent progno-
sis if the exercise echocardiogram is normal (9).
In this study, we examined the outcomes of patients with
good exercise capacity but abnormal exercise echocardio-
grams. We sought to determine if there was an association
between any clinical, exercise or echocardiographic variables
and subsequent cardiac death or nonfatal myocardial infarc-
tion (MI). Late coronary revascularization was included as a
cardiac event in a separate analysis. Echocardiographic
variables analyzed included semiquantitative indices of the
extent and severity of LV systolic dysfunction before and
immediately after exercise.
METHODS
Study group. Data for patients who had exercise echocar-
diography from January 1990 to December 1995 at the
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Mayo Clinic were prospectively entered into a computer
database from which the study population was selected.
Patients who had good exercise capacity (5 METs for
women, 7 METs for men) and abnormal exercise echo-
cardiograms were candidates for the study. These exercise
capacity criteria were selected because the expected tread-
mill time for men is, on average, 2 to 3 min longer than that
for women (10). Patients were excluded if they had been
diagnosed as having hypertrophic, restrictive or idiopathic
dilated cardiomyopathy or if they had significant valvular
heart disease, congenital heart disease or left bundle branch
block. A total of 1,963 patients fulfilled criteria for inclu-
sion. The Institutional Review Board approved the study
protocol.
Exercise echocardiography protocol. Symptom-limited
treadmill-exercise testing was performed in all patients. The
Bruce protocol was used in 95% of patients. Two-
dimensional echocardiographic images at rest and immedi-
ately after exercise were acquired, digitized, recorded and
analyzed according to a previously published protocol (11).
Both digitized and videotaped images were used to interpret
the studies. By definition, all patients had rest or exercise-
induced LV regional wall motion abnormalities. A 16-
segment LV model was used, and all segments were scored
semiquantitatively (12). The segments were scored at rest as
follows: 1, normal; 2, mildly or moderately hypokinetic; 3,
severely hypokinetic or akinetic; 4, dyskinetic; and 5, an
aneurysmal segment. The segments of the images acquired
immediately after exercise were scored as follows: 1, a
normal segment at rest that had a normal hyperdynamic
response to exercise; 2, a normal segment at rest that became
mildly or moderately hypokinetic; 2, a mildly or moderately
hypokinetic segment at rest that improved; 3, a severely
hypokinetic or akinetic segment that improved or did not
worsen; 3, a normal or mildly to moderately hypokinetic
segment at rest that became severely hypokinetic or akinetic;
4, a segment that became dyskinetic; and 5, an aneurysmal
segment. At rest and immediately after exercise, the per-
centage of LV segments that were abnormal (the number of
segments with a score of 2, 3, 4 or 5 divided by 16, then
multiplied by 100) and severely abnormal (that is, severely
hypokinetic or worse [the number of segments with a score
of 3, 4 or 5 divided by 16, then multiplied by 100]) was
calculated. New or worsening wall motion abnormalities
after exercise were interpreted as ischemic responses. The
overall change in LV end-systolic size was assessed visually,
comparing the side-by-side rest and postexercise digitized
images in four standard views (parasternal long axis,
parasternal short axis, apical four-chamber and apical two-
chamber). The LV end-systolic size decreased, did not
change appreciably or increased in response to exercise.
Visual assessments were made of LV ejection fraction at rest
and immediately after exercise (13).
Follow-up. Follow-up information was obtained from
mailed questionnaires, scripted telephone interviews and
reviewed medical records. Of the 1,963 patients who ful-
filled the inclusion criteria, 24 patients declined to partici-
pate in the study. For another 65 patients (3%), there was no
follow-up. Follow-up was complete for 1,874 patients (95%
of eligible patients).
End points. The primary end points considered in the
analysis were cardiac death (sudden death or death preceded
by an acute coronary syndrome or congestive heart failure)
and nonfatal MI. In a separate analysis, late coronary
revascularization was included as an event. All cardiac
events were verified by contacting the patients’ primary
physicians and obtaining medical records or death certifi-
cates. With regard to the timing of coronary revasculariza-
tion after exercise echocardiography, we observed a cluster-
ing of procedures done within the first 30 days, after which
there was a lower, steady rate of coronary revascularization.
Therefore, in the analysis that included coronary revascu-
larization as an event, we did not include patients who had
coronary revascularization within 30 days in an attempt to
reduce the post-test referral bias that might exaggerate the
predictive value of the variables analyzed.
Statistical analysis. Baseline clinical, exercise and echocar-
diographic characteristics of the study group were summa-
rized as the mean value  SD for continuous variables and
as a percentage of the group total for categorical variables.
Cardiac event-free survival was estimated by the Kaplan-
Meier method, using a time-to-first-event approach. Pa-
tients who died of noncardiac causes were censored at the
time of death. Patients who had coronary revascularization
were censored at the time of the procedure for the cardiac
death or nonfatal MI-free survival analysis. For the analysis
of event-free survival, which included late coronary revas-
cularization as a cardiac event, patients who had early (30
days) coronary revascularization were censored. The associ-
ation of clinical, exercise and echocardiographic character-
istics with time to first event was investigated with the Cox
proportional hazards regression model. Univariate and mul-
tivariate predictors were identified for cardiac events con-
sisting of cardiac death or nonfatal MI and for all cardiac
events, including late coronary revascularization. The pair-
wise interaction of variables within the final multivariate
model was also investigated. Hierarchical or incremental
prognostic modeling was also performed to examine the
incremental prognostic value of information obtained from
the exercise electrocardiogram (ECG) and the exercise
echocardiogram.
Abbreviations and Acronyms
CAD  coronary artery disease
CI  confidence interval
ECG  electrocardiogram
LV  left ventricular
METs  metabolic equivalents
MI  myocardial infarction
RR  risk ratio
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RESULTS
Clinical and exercise echocardiographic characteristics.
The mean age of the 1,874 patients was 64  10 years.
Clinical characteristics of the patients are summarized in
Table 1. Of these patients, 897 (48%) had a history of MI
or prior coronary revascularization. For the remaining pa-
tients, the pretest probability of CAD was high, interme-
diate and low in 203 (11%), 397 (21%) and 377 (20%)
patients, respectively (9). The exercise echocardiographic
characteristics of the patients are summarized in Table 2.
The exercise ECG was positive for ischemia in 563 patients
(30%). There were no regional wall motion abnormalities at
rest in 513 patients (27%), and the exercise echocardiogram
was positive for ischemia in 1,243 patients (66%).
Clinical outcome. The mean follow-up period after exer-
cise echocardiography was 3.1  1.6 years (maximum 8
years). There were 59 noncardiac deaths. The cause of death
for these patients was cancer in 34, stroke in 6, infection in
6, trauma in 4 and other causes in 9. There were 107 major
cardiac events observed during the follow-up period; 33
patients had a cardiac death and 74 patients had a nonfatal
MI. Additionally, 70 patients had early coronary revascu-
larization and 159 patients had late coronary revasculariza-
tion.
Multivariate predictors of cardiac death or nonfatal
MI. The overall cardiac death or nonfatal MI rate was 2%
per person-year of follow-up. There were 14 univariate and
3 multivariate predictors of time to cardiac death or nonfatal
MI (Table 3). The multivariate predictors were diabetes
mellitus, history of MI and an increase or no change in LV
end-systolic size in response to exercise. The effect of an
abnormal LV end-systolic size response to exercise on
outcome differed for diabetic and nondiabetic patients (p 
0.04). The estimated risk ratio (RR) was 3.85 (95% confi-
dence interval [CI] 1.6 to 9.1) (p  0.003) for diabetic
patients and 1.4 (95% CI 0.9 to 2.1) (p  0.18) for
nondiabetic patients.
Incremental prognostic value of exercise ECG and exer-
cise echocardiography. To examine the incremental prog-
nostic value of exercise ECG and echocardiographic vari-
ables over clinical information, we sequentially added the
exercise ECG and then the echocardiographic variables to a
clinical prognostic model. The global chi-square value for
the clinical model was 31. In this cohort with good exercise
capacity and abnormal exercise echocardiograms, exercise
ECG variables did not add prognostic information to the
clinical model (largest obtainable global chi-square  33,
p  0.16). For exercise echocardiographic variables, the
change in LV end-systolic size in response to exercise
provided the greatest incremental prognostic value (global
chi-square  37, p  0.046 vs. the clinical model plus
exercise ECG). This was similar to the chi-square value
obtained when the percentage of LV segments that were
severely abnormal immediately after exercise was considered
(global chi-square  37, p  0.046).
Stratification of cardiac risk. For the 1,330 patients (71%)
who had a decrease in LV end-systolic size in response to
exercise, the cardiac death or nonfatal MI rate per person-
year of follow-up was 1.6% versus 2.9% for the 544 patients
(29%) with an increase or no change in LV end-systolic size
(Figs. 1A and 2). For patients with diabetes (n  130) who
had an increase or no change in LV end-systolic size, the
event rate was 7.5% per person-year of follow-up.
Patients who did not have any severely abnormal (severely
hypokinetic or worse) LV segments immediately after ex-
Table 2. Exercise Echocardiographic Characteristics
Characteristic Patients (%)*
Workload achieved
10 METs 65
10 METs 35
Functional aerobic capacity (%  SD) 110  27
Heart rate, maximal (beats/min  SD) 143  22
85% age-predicted maximal heart rate achieved 71
Rate-pressure product, peak ( SD) 25,813  6,236
Exercise hypertension (peak SBP  240 mm Hg) 11
Exercise hypotension (peak SBP  rest SBP) 5
Angina during TMET 12
Exercise ECG
Negative for ischemia 45
Positive for ischemia 30
Nondiagnostic 25
Echo LV enlargement 16
Echo EF
Rest (%  SD) 54  9
Exercise (%  SD) 59  11
Exercise echo positive for ischemia 66
Decrease in LV end-systolic size 71
Increase or no change in LV end-systolic size 29
*Unless otherwise noted.
ECG  electrocardiogram; EF  ejection fraction; LV  left ventricular;
METs  metabolic equivalents; SBP  systolic blood pressure; TMET  treadmill
exercise test.
Table 1. Clinical Characteristics of the Study Group
Characteristic Patients (%)
Men 64
Chest pain history
Typical angina 25
Atypical chest pain 32
None 43
Hypertension 49
Diabetes mellitus 11
Smoking, current or past 57
Hyperlipidemia 59
Family history of CAD 40
History of MI 34
Prior coronary revascularization 36
Medications
Beta-blockers 31
Calcium channel blockers 33
Digoxin 8
Rest ECG
Normal 33
Q-waves 25
ST-T changes 49
CAD  coronary artery disease; ECG  electrocardiogram; MI  myocardial
infarction.
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ercise (mildly abnormal, n  868, 46% of patients) had a
favorable outcome, with a cardiac death or nonfatal MI rate
of only 1.2% per person-year of follow-up. Those who had
severe abnormalities in 1% to 25% of LV segments imme-
diately after exercise (moderately abnormal, n  657, 35%
of patients) had a cardiac death or nonfatal MI rate of 2.2%,
and patients who had severe abnormalities in more than
25% of LV segments immediately after exercise (markedly
abnormal, n  349, 19% of patients) had a cardiac death or
nonfatal MI rate of 3.8% (Figs. 1B and 3).
Patients who had early coronary revascularization. The
70 patients (4%) who had coronary revascularization within
30 days after the exercise echocardiogram were compared
with the 1,804 patients who did not have early coronary
revascularization. These 70 patients were just as likely to
have diabetes mellitus or a history of MI, but more often
had an increase or no change in LV end-systolic size in
response to exercise (63% vs. 28%, p  0.001). Consistent
with this descriptor of severe postexercise LV dysfunction,
these patients had more extensive ischemia (25% of LV
segments became ischemic in 59% vs. 20%, p  0.001) and
more extensive severe regional wall motion abnormalities
immediately after exercise (25% of LV segments were
severely abnormal in 41% vs. 18%, p  0.001). Of the 70
patients who had early coronary revascularization, 2 had
periprocedural MIs; 1 MI was fatal. The other 68 patients
had good outcomes, with a subsequent cardiac death or
nonfatal MI rate of 0.5% per person-year of follow-up (vs.
2% for those patients who did not have early revasculariza-
tion).
Late coronary revascularization as a cardiac event. When
late coronary revascularization was included as a cardiac
event, the number of cardiac events observed was 266, and
this cardiac event rate per person-year of follow-up was 5%.
There were 24 univariate (data not shown) and 7 multivar-
iate predictors of cardiac death, nonfatal MI, or late coro-
nary revascularization. The multivariate predictors were
diabetes mellitus (RR 1.80 [95% CI 1.3 to 2.5], p 
0.0003), history of typical angina (RR 1.65 [95% CI 1.3 to
2.2], p  0.0002), history of MI (RR 1.45 [95% CI 1.1 to
1.9], p  0.007), hypertension (RR 1.36 [95% CI 1.1 to
1.9], p  0.02), angina during the treadmill test (RR 1.48
[95% CI 1.1 to 2.1], p  0.02), peak rate-pressure product
(RR 0.44 [95% CI 0.3 to 0.7], p  0.0003) and percentage
of LV segments that were severely abnormal immediately
after exercise (RR 1.28 [95% CI 1.1 to 1.5], p  0.001).
For the incremental prognostic model, the following
global chi-square values for the different models were
determined: clinical model, chi-square  44 (important
variables: diabetes mellitus, history of MI and prior coronary
revascularization); clinical model plus exercise ECG vari-
ables, chi-square  75, p  0.0001 versus clinical model
(important variables: angina during the treadmill test, peak
rate-pressure product and exercise ECG positive for isch-
emia); and clinical model plus exercise ECG plus exercise
echocardiography, chi-square  84, p  0.003 versus
Table 3. Univariate and Multivariate Predictors* of Outcome
Cardiac Death or Nonfatal MI
Risk Ratio
(95% CI)
p
Value
Univariate predictor of outcome
Diabetes mellitus 2.25 (1.4–3.6) 0.0007
Prior coronary revascularization 2.05 (1.4–3.0) 0.0002
History of MI 2.63 (1.8–3.9) 0.0001
Rest ECG normal 0.54 (0.3–0.9) 0.008
Enlarged LV at rest 1.67 (1.1–2.5) 0.02
Echo EF, rest (per 10%) 0.74 (0.7–0.9) 0.002
Exercise echo positive for ischemia 0.68 (0.5–1.0) 0.05
Increase or no change in LV end-systolic size 1.75 (1.3–2.5) 0.004
Echo EF, peak (per 10%) 0.82 (0.7–0.9) 0.0008
No change or decrease in EF 1.75 (1.2–2.6) 0.005
% of LV segments
Abnormal at rest 1.53 (1.2–1.9) 0.0001
Severely abnormal at rest 1.53 (1.2–1.9) 0.0002
Abnormal immediately after exercise 1.38 (1.1–1.7) 0.006
Severely abnormal immediately after exercise 1.55 (1.3–1.9) 0.0001
Multivariate predictor of outcome
Diabetes mellitus 1.88 (1.2–3.0) 0.009
History of MI 2.44 (1.6–3.6) 0.0001
Increase or no change in LV end-systolic size 1.61 (1.1–2.5) 0.02
*The following other (nonsignificant) variables were tested: age; gender; smoking; hypertension; family history of coronary artery
disease; hyperlipidemia; history of typical angina; use of beta-blockers, calcium channel blockers or digoxin at the time of
treadmill exercise text; rest heart rate; ECG and echo left ventricular hypertrophy; maximal heart rate;  85% of age-predicted
maximal heart rate achieved; maximal systolic and diastolic blood pressure; peak rate-pressure product; functional aerobic
capacity; exercise hypotension or hypertension; angina during treadmill exercise test; exercise electrocardiogram (ECG) positive;
% of left ventricular (LV) segments ischemic; and presence of both rest and ischemic wall motion abnormalities.
CI  confidence interval; EF  ejection fraction; MI  myocardial infarction.
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clinical model plus exercise ECG (important variable: the
percentage of LV segments that were severely abnormal
immediately after exercise).
Patients with excellent exercise capacity. Of the patients,
658 (35%) were able to exercise 10 METs. In this
subgroup of patients with excellent exercise capacity, 20%
Figure 1. (A) Event-free (cardiac death or nonfatal myocardial infarction) survival of patients according to the response of the left ventricular (LV)
end-systolic size to exercise. The one-, three- and five-year event-free survival rates for patients with a decrease in LV end-systolic size in response to exercise
were 98.7  0.3%, 95.8  0.7% and 91.1  1.3%, respectively (event rate 1.6%); and for patients with an increase or no change in LV end-systolic size,
98.0  0.6%, 93.7 1.3% and 86.2  2.6%, respectively (event rate 2.9%). (B) The percentage of LV segments that were severely abnormal immediately
after exercise. The one-, three- and five-year event-free survival rates for patients with 0% of LV segments severely abnormal immediately after exercise were
99.3  0.3%, 96.6  0.7% and 93.8  1.3%, respectively (event rate 1.2%); for patients with 1% to 25% of LV segments severely abnormal, 97.7  0.6%,
93.5  1.2% and 91.3  1.6%, respectively (event rate 2.2%); and for patients with 25% of LV segments severely abnormal, 97.8  0.8%, 95.0  1.4%
and 75.2  4.8%, respectively (event rate 3.8%).
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had an increase or no change in LV end-systolic size in
response to exercise (compared with 34% of those patients
who had good exercise capacity [5 METs for women, 7
METs for men, but 10 METs]). Patients with excellent
exercise capacity had similar outcomes compared with
patients who had good exercise capacity; the one-, three-
and five-year cardiac death or nonfatal MI-free survival rates
for patients who exercised 10 METs were 97.9  0.6%,
95.3  1.0%, and 90.2  2.1%, respectively, and for
patients who exercised 10 METs, 98.8  0.3%, 95.3 
0.7%, and 89.6  1.5%, respectively.
DISCUSSION
It is known that patients with CAD who have excellent
exercise capacity have a favorable prognosis (1,2). In this
Figure 2. Event rates per person-year of follow-up for patients with normal exercise echocardiography (data for 1,181 patients with good exercise capacity [9])
and for patients with a decrease and an increase or no change in left ventricular (LV) end-systolic size in response to exercise. MI  myocardial infarction.
Figure 3. Event rates per person-year of follow-up for patients with normal exercise echocardiography (Fig. 2) and for patients with 0%, 1% to 25% and
25% of left ventricular (LV) segments severely abnormal immediately after exercise. MI  myocardial infarction.
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study of patients with known or suspected CAD, we
examined the outcomes of patients with good exercise
capacity (as defined) and different degrees of exercise echo-
cardiographic abnormalities. The following important clin-
ical question was addressed in this study: What, if any, are
the prognostic implications of an abnormal exercise echo-
cardiogram for patients who are able to exercise adequately?
It was not our intention to examine the outcomes of all
patients who had exercise echocardiography. We deliber-
ately excluded patients with normal exercise echocardio-
grams and those with reduced exercise capacity.
The current study. In this large group of patients with
good exercise capacity, certain exercise echocardiographic
variables were of incremental prognostic value when added
to clinical and exercise ECG data and facilitated cardiac risk
stratification of the study population. These variables, the
change in LV end-systolic size in response to exercise and
the percentage of LV segments that were severely abnormal
(severely hypokinetic or worse) immediately after exercise,
are descriptors of the extent and severity of exercise-related
LV dysfunction. These two variables were more important
than other variables, such as rest and exercise ejection
fraction, the extent and severity of rest LV wall motion
abnormalities and the presence and extent of exercise-
induced myocardial ischemia. Both variables are a summa-
tion of LV function or dysfunction at rest plus any exercise-
induced myocardial ischemia. When late coronary
revascularization was included as an event, the percentage of
LV segments that were severely abnormal immediately after
exercise was the most important echocardiographic variable
for prognosis prediction and was of incremental prognostic
value.
Comparison with previous studies. Many studies have
validated the notion that the noninvasive evaluation of
patients with known or suspected CAD by exercise or
pharmacologic stress radionuclide perfusion imaging tech-
niques can provide incremental prognostic information and
lead to appropriate risk stratification and cost-effective
management strategies (6). Several studies have demon-
strated that radionuclide myocardial perfusion imaging has
incremental prognostic value over clinical and exercise data
when major cardiac events or total events (major events and
late coronary revascularization) are used as end points (6).
The prognostic value of exercise echocardiography in
ambulatory, outpatient populations has been examined
more recently (8,14–16). The first study to compare the
prognostic power of exercise echocardiography and nuclear
scintigraphy in the same patients showed that the variables
of cardiac function and perfusion measured by these two
imaging techniques were equally powerful in distinguishing
patients at low risk for cardiac events from those at high risk
(8). In that study, the exercise wall motion score index,
another descriptor of the severity of LV dysfunction, was
the most important echocardiographic predictor of cardiac
events. The wall motion score index is a summary of LV
segmental wall motion abnormalities and does not readily
differentiate between abnormal and severely abnormal seg-
ments. In the present study, we chose to make the distinc-
tion between abnormal and severely abnormal segments and
counted them. This enabled us to analyze the potential
prognostic implications of abnormal versus severely abnor-
mal segments. We were thus able to identify a large
subgroup of patients without severe wall motion abnormal-
ities who were at low risk of having a major cardiac event.
Investigators using exercise nuclear scintigraphy have simi-
larly been able to stratify patients into low- and higher-risk
subgroups, on the basis of the extent and severity of
exercise-related LV myocardial perfusion abnormalities
(17–20).
The only high-risk subgroup of patients that we identi-
fied included patients with diabetes who had an abnormal
response of the LV end-systolic size to exercise. The 70
patients who were censored in the event-free survival
analyses because they had early coronary revascularization
could also have been a higher risk subgroup, because most
had an increase or no change in LV end-systolic size in
response to exercise and extensive exercise-induced myocar-
dial ischemia. Analysis of this patient subgroup suggests
that early coronary revascularization can offer an outcome
advantage to some patients with good exercise capacity but
abnormal exercise echocardiography.
Study limitations. Our definition of good exercise capacity
is approximate because exercise capacity is a function of
both gender and age. By gender- and age-specific aerobic
capacity criteria, some patients had only fair or low exercise
capacity (21). We selected the cutpoints of 5 METs for
women and 7 METs for men because we showed previously
that the outcome of such patients is excellent if the exercise
echocardiogram is normal (9). These cutpoints are also
simple to use in clinical practice.
Patient follow-up was not 100% complete, and it aver-
aged three years. The results of exercise echocardiography
were known to the patients’ physicians and undoubtedly
played a role in patient management decisions. We at-
tempted to minimize the effects of post-test referral bias by
censoring patients who had early coronary revascularization.
The exercise echocardiograms were interpreted by expe-
rienced level III echocardiologists who work in a large
clinical echocardiography laboratory at a tertiary medical
center. The visual assessment of rest and exercise regional
and global LV function, on which this and other studies are
based, is an interpretive skill that can be mastered, but one
that requires extensive training and ongoing experience.
One of the more straightforward aspects of exercise echo-
cardiographic interpretation, however, is the side-by-side
comparison of LV end-systolic size at rest and immediately
after exercise that digitizing technology permits. This as-
sessment of the change in LV end-systolic size in response
to stress has been validated by comparing it with the more
exacting biplane “method of discs” measurement of LV
end-systolic volume (22,23). Because there is interinstitu-
tional variability in interpretation of stress echocardiograms
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(24), the findings of this study ideally should be confirmed
in other patient populations.
Conclusions. For patients with good exercise capacity but
abnormal exercise echocardiograms, echocardiographic de-
scriptors of the extent and severity of exercise-related LV
dysfunction were of independent and incremental prognos-
tic value. This information can be used to stratify patients
into low- and higher-risk subgroups.
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